Maternal immunization: Optimizing protection for the mother and infant
Kachikis A, Englund JA. Journal of Infection 2016; 72: S83-90. Artículo de revisión sobre la vacunación de la embarazada. La vacunación de la mujer embarazada…
Leer más
Pertussis: Where did we go wrong and what can we do about it?
Locht C. Journal of Infection 2016; 72: S34-40. Artículo de revisión que repasa diferentes aspectos de la tosferina. La enfermedad ha sufrido un importante aumento…
Preventing cervical cancer and genital warts – How much protection is enough for HPV vaccines?
Stanley M. Journal of Infection 2016; 72: S13-22. Artículo de revisión elaborado por Margaret Stanley que nos aproxima a las vacunas frente al VPH; en…
Immunisation of the immunocompromised child
Pinto MV, Bihari S, Snape MD. Journal of Infection 2016; 72: S13-22. Artículo de revisión que aborda el tema de la vacunación en niños inmunodeprimidos.…
High levels of susceptibility to measles, mumps and rubella (MMR) in HIV-infected individuals in Ireland
Sadlier C, Carr A, Bergin C. Journal of Infection 2016; 73(1): 84-6. El objetivo del estudio es analizar la frecuencia de susceptibles a sarampión, rubeola…
Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England
van Hoek AJ, Campbell H, Amirthalingam G, Andrews N, Miller E. Journal of Infection 2016; 73(1): 28-37. El programa de vacunación de la embarazada frente…
Neurological sequelae of bacterial meningitis
Lucas MJ, Brouwer MC, van de Beek D. Journal of Infection 2016; 73(1): 18-27. Artículo de revisión que tiene como objetivo describir la frecuencia, impacto…
Detrimental effects of introducing partial compulsory vaccination: experimental evidence
Betsch C, Böhm R. Eur J Public Health 2016; 26(3) 378-81. El trabajo tiene como objetivo medir el efecto de la vacunación obligatoria sobre determinadas…
Public health needs of migrants, refugees and asylum seekers in Europe, 2015: Infectious disease aspects
Semenza JC, Carrillo-Santisteve P, Zeller H, Sandgren A, van der Werf MJ, Severi E et al. Eur J Public Health 2016; 26(3) 372-3. El artículo…
Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States
Atkins KE, Fitzpatrick MC, Galvani AP, Townsend JP. Am. J. Epidemiol 2016; 183 (12): 1159-70. El objetivo del trabajo es evaluar el coste-efectividad de la…
Bayesian Correction of Misclassification of Pertussis in Vaccine Effectiveness Studies: How Much Does Underreporting Matter?
Goldstein ND, Burstyn I, Newbern EC, Tabb LP, Gutowski J, Welles SL. Am. J. Epidemiol 2016; 183 (11): 1063-70. El diagnóstico de la tosferina es…
Relating Pneumococcal Carriage Among Children to Disease Rates Among Adults Before and After the Introduction of Conjugate Vaccines
Weinberger DM, Grant LR, Weatherholtz RC, Warren JL, O’Brien KL, Hammitt LL. Am. J. Epidemiol 2016; 183 (11): 1055-62. El uso de las vacunas neumocócicas…
What Transmission Precautions Best Control Influenza Spread in a Hospital?
Blanco N, Eisenberg MC, Stillwell T, Foxman B. Am. J. Epidemiol 2016; 183 (11): 1045-54. Las estrategias de prevención y control de la gripe en…
Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children
Klein NP, Baine Y, Kolhe D, Baccarini CI, Miller JM, Van der Wielen M. Pediatr Infect Dis J 2016; 35(6): 662-72. El objetivo del estudio…
A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents
Muse D, Christensen S, Bhuyan P, Absalon J, Eiden JJ, Jones TR et al. Pediatr Infect Dis J 2016; 35(6): 673-82. Ensayo clínico fase 2,…
Sustained Decrease in Gastroenteritis-related Deaths and Hospitalizations in Children Less Than 5 Years of Age After the Introduction of Rotavirus Vaccination: A Time–Trend Analysis in Brazil (2001–2010)
Costa I, Linhares AC, Cunha MH, Tuboi S, Argüello DF, Justino MC et al. Pediatr Infect Dis J 2016; 35(6): e180-90. La vacuna frente al…
Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia
Andrade DC, Borges IC, Adrian PV, Meinke A, Barral A, Ruuskanen O et al. Pediatr Infect Dis J 2016; 35(6): 683-9. Tres de las bacterias…
Coverage and Determinants of Uptake for Privately Funded Rotavirus Vaccine in a Canadian Birth Cohort, 2008–2013
MacDonald SE, Bell CA, Simmonds KA. Pediatr Infect Dis J 2016; 35(6): e177-9. Estudio retrospectivo de base poblacional que tiene como objetivo medir la cobertura…
Maternal and neonatal pneumococcal vaccination – where are we now?
Clarkea E, Kampmanna B and Goldblatt D. Expert Rev. Vaccines 2016; (on-line): 1–13. El neumococo es un patógeno importante en los recién nacidos y en…
Childhood and adolescent influenza vaccination in Europe: A review of current policies and recommendations for the future
McGuire A, Drummond M and Keeping S. Expert Rev. Vaccines 2016; (5): 659-670. Los niños y adolescentes tienen una de las tasas más altas de…
Routinely vaccinating adolescents against meningococcus: targeting transmission & disease
Vettera V, Baxterb R, Denizera G, Sáfadic MAP, Silfverdald S-A, Vysea A and Borrowe R. Expert Rev. Vaccines 2016; (5): 641–658. Los adolescentes tienen las…
Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases
Skinner SR, Apter D, De Carvalho N, Harper DM, Konno R, Paavonen J, Romanowski B, Roteli-Martins C, Burlet N, Mihalyi A and Struyf F. Expert…
Pneumococcal conjugate vaccine use in adults
Isturiz RE, Schmoele-Thomab B, Scottc DA, Jodara L, Webberd C, Singsa HL and Paradiso P. Expert Rev. Vaccines 2016; (3): 279–292. El Streptococcus pneumoniae es…
The most effective and promising population health strategies to advance human papillomavirus vaccination
Jacobson RM, Roberts JR and Darden PM. Expert Rev. Vaccines 2016; (2): 257-269. Los EE.UU. está fallando para hacer un progreso sustancial hacia la mejora…
Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines
Bekkat-Berkani R, Ray R, Jain VK, Chandrasekaran V and Innis BL. Expert Rev. Vaccines 2016; (2): 201-214. Las vacunas antigripales inactivadas trivalentes (IIV3s) están diseñadas…
